Development of a floating multiple unit controlled-release system for mosapride
Main Article Content
Abstract
percentage of mosapride content from the beads was determined by high-performance liquid chromatography (HPLC) and ranged from 97.9  0.08 to 99.6  0.01. The in-vitro percentage release of mosapride from the beads at the end of 14 hours ranged from 90.0  0.2 to 99.5  0.12. The formulated beads in formulations 1 and 3 were sealed in vials and kept for 90 days at 40°C / 75% RH. After 90 days of exposure the percentage drug content was found to be 99.2  0.04. The Floating beads designed for the gastroretentive dosage form could be suitable for controlled drug delivery.
Downloads
Article Details
This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.
References
Hirtz J. The gastrointestinal absorption of drugs in man: a review of
current concepts and methods of investigation. Br J Clin Pharmacol
;19:77S-83S.
Lachman L, Lieberman H, Joseph K. Theory and practice of industrial
pharmacy. 3rd ed. Mumbai: Varaghese publishing house; 1987. p. 430-4.
Klausner EA, Lavy E, Friedman M, Hoffman A. Expandable gastroretentive dosage forms. J Control Release 2003;90:143-62.
Rouge N, Buri P, Doelker E. Drug absorption sites in the gastro
intestinal tract and dosage forms for site-specific delivery. Int J Pharm
;136:117-39.
Choi BY, Park HJ, Hwang SJ, Park JB. Preparation of alginate beads for
floating drug delivery system: Effects of CO2 gas forming agents. Int J
Pharm 2002;239:81-91.
Deshpande AA, Rhodes CT, Shah NH, Malick AW. Controlled release
drug delivery systems for prolonged residence an overview. Drug Dev
Ind Pharm 1997;22:531-9.
Nadia P, Beatrice P, Beatrice A, Dario V, Mariarosa M, Lorenzo R.
Controlled release of Verapamil HCl from waxy micro particles by spray
congealing. J Control Release 2003;93:115-22.
Shu XZ, Zhu KJ. A novel approach to prepare tripolyphosphate/
chitosan complex beads for controlled release drug delivery. Int J
Pharm 2000;201:51-8.
Lynne W, John H, John T. Amoxycillin release from a floating dosage
form based on alginates. Int J Pharm 2000;210:45-9.
Krishnaiah YS, Murthy TK, Sankar DK, Satyanarayana V. Determination
of mosapride citrate in bulk drug samples and pharmaceutical dosage
forms using HPLC. Anal Sci 2002;18:1269-71.
Krishnaiah YS, Murthy TK, Sankar DG, Satyanarayana V. A validated
RP-HPLC method for the determination of mosapride citrate in bulk
drug samples and pharmaceutical formulations. Pharmazie 2002;57:
-6.
ICH harmonized tripartite guideline: Stability testing of new drug
substances and products Q1A (R2). 2003.